357 related articles for article (PubMed ID: 32879947)
21. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
[TBL] [Abstract][Full Text] [Related]
22. Impella CP use in patients with non-ischaemic cardiogenic shock.
Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
[TBL] [Abstract][Full Text] [Related]
24. Propensity score-based analysis of 30-day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices.
Nersesian G; Potapov EV; Nelki V; Stein J; Starck C; Falk V; Schoenrath F; Krackhardt F; Tschöpe C; Spillmann F
J Card Surg; 2021 Nov; 36(11):4141-4152. PubMed ID: 34460968
[TBL] [Abstract][Full Text] [Related]
25. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
[TBL] [Abstract][Full Text] [Related]
26. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
[TBL] [Abstract][Full Text] [Related]
27. The Impella® Recover mechanical assist device in acute cardiogenic shock: a single-centre experience of 66 patients.
Schiller P; Vikholm P; Hellgren L
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):452-8. PubMed ID: 26763043
[TBL] [Abstract][Full Text] [Related]
28. Use of Impella heart pump for management of women with peripartum cardiogenic shock.
Elkayam U; Schäfer A; Chieffo A; Lansky A; Hall S; Arany Z; Grines C
Clin Cardiol; 2019 Oct; 42(10):974-981. PubMed ID: 31436333
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with temporary right ventricular mechanical circulatory support.
Bhama JK; Bansal U; Winger DG; Teuteberg JJ; Bermudez C; Kormos RL; Bansal A
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1885-1891. PubMed ID: 29861112
[TBL] [Abstract][Full Text] [Related]
30. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
[TBL] [Abstract][Full Text] [Related]
31. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of hundred large Impella implantations in cardiogenic shock patients based on individual clinical scenarios.
Sugimura Y; Bauer S; Immohr MB; Mehdiani A; Rellecke P; Tudorache I; Horn P; Westenfeld R; Boeken U; Aubin H; Lichtenberg A; Akhyari P
Artif Organs; 2023 Dec; 47(12):1874-1884. PubMed ID: 37724611
[TBL] [Abstract][Full Text] [Related]
33. Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock.
Madjarov JM; Katz MG; Madzharov S; Fazal S; Robicsek F
J Cardiothorac Surg; 2021 May; 16(1):132. PubMed ID: 34001192
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group.
Fried J; Farr M; Kanwar M; Uriel N; Hernandez-Montfort J; Blumer V; Li S; Sinha SS; Garan AR; Li B; Hall S; Hickey GW; Mahr C; Nathan S; Schwartzman A; Kim J; Ton VK; Vishnevsky OA; Vorovich E; Abraham J; Zweck E; Guglin M; Vallabhajosyula S; Kataria R; Walec KD; Zazzali P; Kong Q; Sangal P; Burkhoff D; Kapur NK
J Heart Lung Transplant; 2024 Jun; ():. PubMed ID: 38834162
[TBL] [Abstract][Full Text] [Related]
35. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
[TBL] [Abstract][Full Text] [Related]
36. Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.
Napp LC; Westenfeld R; Møller JE; Pappalardo F; Ibrahim K; Bonello L; Wilkins C; Pershad A; Mannino SF; Schreiber TL; Hall PA; Medjamia AM; Haurand JM; Sieweke JT; Schäfer A; Grines CL; Burkhoff D; Moses JW; Ohman EM; O'Neill WW; Kapur NK; Bauersachs J
Cardiovasc Revasc Med; 2022 Jul; 40():113-119. PubMed ID: 34916157
[TBL] [Abstract][Full Text] [Related]
37. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery.
La Torre MW; Centofanti P; Attisani M; Patanè F; Rinaldi M
Tex Heart Inst J; 2011; 38(1):42-9. PubMed ID: 21423467
[TBL] [Abstract][Full Text] [Related]
38. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L
J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547
[TBL] [Abstract][Full Text] [Related]
39. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
[TBL] [Abstract][Full Text] [Related]
40. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
